1. Treatment C for SA. Chapter 4—Oral Naltrexone. Substance Abuse and Mental Health Services Administration (US); 2009. Available from: https://www.ncbi.nlm.nih.gov/books/NBK64042/. [Last accessed on 2022 Mar 18].
2. Available from: https://www.accessdata.fda.gov/drugsatfda_docs/nda/2006/021897s000_Approv.pdf. [Last accessed on 2022 Apr 25].
3. Naltrexone – ClinicalKey. Available from: https://www.clinicalkey.com/#!/content/drug_monograph/6-s20.0-426?scrollTo=%23Indications. [Last accessed on 2022 Apr 25].
4. Efficacy of low dose naltrexone as an immune stabilizing agent for the treatment of HIV/AIDS;Bihari;AIDS Patient Care,1995
5. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance;Hotamisligil;Science,1993